David L. Berry
- Cancer Research top 5%
- Molecular Biology
- Oncology top 10%
- Health, Toxicology and Mutagenesis top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Co-authors
- Thomas J. SlagaMont R. JuchauJohn DiGiovanniWilliam M. BrackenAurora ViajeGerhard FürstenbergerFriedrich MarksBarbara A. Sorg
- Topics
- Carcinogens and Genotoxicity Assessment (11 papers)Synthesis of Organic Compounds (8 papers)Biological Activity of Diterpenoids and Biflavonoids (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesGermanySweden
In The Last Decade
David L. Berry
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 508
- Molecular Biology 428
- Oncology 315
- Health, Toxicology and Mutagenesis 247
- Pediatrics, Perinatology and Child Health 191
Countries citing papers authored by David L. Berry
This map shows the geographic impact of David L. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Berry more than expected).
Fields of papers citing papers by David L. Berry
This network shows the impact of papers produced by David L. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Berry. The network helps show where David L. Berry may publish in the future.
Co-authorship network of co-authors of David L. Berry
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Berry. A scholar is included among the top collaborators of David L. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Berry. David L. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 248 | |
| 7 | 90 | |
| 8 | Amniotic septostomy for the treatment of the stuck twin sequence | 1 |
| 9 | 9 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 24 | |
| 13 | 34 | |
| 14 | 16 | |
| 15 | 2 | |
| 16 | 24 | |
| 17 | The effects of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) and aroclor 1254 on 7,12-dimethylbenz[a]-anthracene metabolism and tumor initiating activity in mouse skin | 1 |
| 18 | Metabolic conversion of 12-O-tetradecanoylphorbol-13-acetate in adult and newborn mouse skin and mouse liver microsomes. | 29 |
| 19 | 32 | |
| 20 | Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys. Correlations with aryl hydrocarbon hydroxylase activities. | 15 |
About David L. Berry
David L. Berry is a scholar working on Cancer Research, Pharmacology and Health, Toxicology and Mutagenesis, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (11 papers), Synthesis of Organic Compounds (8 papers) and Biological Activity of Diterpenoids and Biflavonoids (5 papers). The work is most often cited by research in Cancer Research (508 citations), Pharmacology (172 citations) and Health, Toxicology and Mutagenesis (247 citations). David L. Berry has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Thomas J. Slaga, Mont R. Juchau, John DiGiovanni, William M. Bracken, Aurora Viaje, Gerhard Fürstenberger, Friedrich Marks, Barbara A. Sorg, S. Eva Singletary and Aman U. Buzdar. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.